AVIR
Atea Pharmaceuticals Inc
5.30$
-6.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | 610.1% | -24.8% | -63.0% | – | – | – | |
| – | – | 0.0% | 0.0% | 0.1% | – | – | – | |
| – | – | 15.3% | 11.3% | 24.3% | – | – | – | |
| – | – | 15.3% | 11.3% | 21.5% | – | – | – | |
| – | – | 617.3% | -70.5% | -24.2% | – | – | – | |
| – | – | 0.1% | 0.0% | 1.0% | – | – | – | |
| – | – | -0.1% | 0.0% | -237.0% | – | – | – | |
| – | – | 1,093.4% | 0.4% | – | – | – | – | |
| – | – | 1,093.4% | 0.4% | 0.2% | – | – | – | |
| – | – | 1,703.5% | -24.3% | -299.7% | – | – | – | |
| – | – | 610.1% | -24.8% | -64.0% | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.